Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lorrey SJ"'
Autor:
Ormhøj M, Scarfò I, Cabral ML, Bailey SR, Lorrey SJ, Bouffard AA, Castano AP, Larson RC, Riley LS, Schmidts A, Choi BD, Andersen RS, Cédile O, Nyvold CG, Christensen JH, Gjerstorff MF, Ditzel HJ, Weinstock DM, Barington T, Frigault MJ, Maus MV
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2286.
Autor:
Lerner EC; Duke University School of Medicine, Durham, NC, USA.; Department of Biomedical Engineering, Duke University, Durham, NC, USA., Woroniecka KI; Department of Pathology, Duke University Medical Center, Durham, NC, USA., D'Anniballe VM; Duke University School of Medicine, Durham, NC, USA., Wilkinson DS; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Mohan AA; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Lorrey SJ; Department of Immunology, Duke University Medical Center, Durham, NC, USA., Waibl-Polania J; Department of Pathology, Duke University Medical Center, Durham, NC, USA., Wachsmuth LP; Duke University School of Medicine, Durham, NC, USA.; Department of Pathology, Duke University Medical Center, Durham, NC, USA., Miggelbrink AM; Department of Pathology, Duke University Medical Center, Durham, NC, USA., Jackson JD; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Cui X; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Raj JA; Duke University School of Medicine, Durham, NC, USA., Tomaszewski WH; Department of Immunology, Duke University Medical Center, Durham, NC, USA., Cook SL; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Sampson JH; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Patel AP; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Center for Advanced Genomic Technologies, Duke University, Durham, NC, USA., Khasraw M; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA., Gunn MD; Department of Immunology, Duke University Medical Center, Durham, NC, USA.; Department of Medicine, Duke University Medical Center, Durham, NC, USA., Fecci PE; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA. peter.fecci@duke.edu.; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA. peter.fecci@duke.edu.
Publikováno v:
Nature cancer [Nat Cancer] 2023 Sep; Vol. 4 (9), pp. 1258-1272. Date of Electronic Publication: 2023 Aug 03.
Autor:
Lorrey SJ; Department of Immunology, Duke University, Durham, NC, USA.; Brain Tumor Immunotherapy Program, Duke University, Durham, NC, USA., Waibl Polania J; Brain Tumor Immunotherapy Program, Duke University, Durham, NC, USA.; Department of Pathology, Duke University, Durham, NC, USA., Wachsmuth LP; Brain Tumor Immunotherapy Program, Duke University, Durham, NC, USA.; Department of Pathology, Duke University, Durham, NC, USA.; Medical Scientist Training Program, Duke University, Durham, NC, USA., Hoyt-Miggelbrink A; Brain Tumor Immunotherapy Program, Duke University, Durham, NC, USA.; Department of Pathology, Duke University, Durham, NC, USA., Tritz ZP; Department of Immunology, Mayo Clinic, Rochester, MN, USA., Edwards R; Brain Tumor Immunotherapy Program, Duke University, Durham, NC, USA., Wolf DM; Department of Immunology, Mayo Clinic, Rochester, MN, USA., Johnson AJ; Department of Immunology, Mayo Clinic, Rochester, MN, USA., Fecci PE; Department of Immunology, Duke University, Durham, NC, USA.; Brain Tumor Immunotherapy Program, Duke University, Durham, NC, USA.; Department of Pathology, Duke University, Durham, NC, USA.; Department of Neurosurgery, Duke University, Durham, NC, USA., Ayasoufi K; Department of Immunology, Mayo Clinic, Rochester, MN, USA.
Publikováno v:
Neuro-oncology advances [Neurooncol Adv] 2023 Apr 11; Vol. 5 (1), pp. vdad035. Date of Electronic Publication: 2023 Apr 11 (Print Publication: 2023).
Autor:
Miggelbrink AM; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Jackson JD; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Lorrey SJ; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Department of Immunology, Duke University Medical Center, Durham, North Carolina., Srinivasan ES; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Duke University School of Medicine, Durham, North Carolina., Waibl-Polania J; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Wilkinson DS; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Fecci PE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina. peter.fecci@duke.edu.; Department of Pathology, Duke University Medical Center, Durham, North Carolina.; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Department of Immunology, Duke University Medical Center, Durham, North Carolina.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Nov 01; Vol. 27 (21), pp. 5742-5752. Date of Electronic Publication: 2021 Jun 14.
Autor:
Grabowski MM; Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, 303 Research Drive, 220 Sands Bldg, Durham, NC, 27710, USA., Sankey EW; Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, 303 Research Drive, 220 Sands Bldg, Durham, NC, 27710, USA., Ryan KJ; Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, 303 Research Drive, 220 Sands Bldg, Durham, NC, 27710, USA., Chongsathidkiet P; Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, 303 Research Drive, 220 Sands Bldg, Durham, NC, 27710, USA., Lorrey SJ; Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, 303 Research Drive, 220 Sands Bldg, Durham, NC, 27710, USA., Wilkinson DS; Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, 303 Research Drive, 220 Sands Bldg, Durham, NC, 27710, USA., Fecci PE; Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, 303 Research Drive, 220 Sands Bldg, Durham, NC, 27710, USA. peter.fecci@duke.edu.
Publikováno v:
Journal of neuro-oncology [J Neurooncol] 2021 Jan; Vol. 151 (1), pp. 3-12. Date of Electronic Publication: 2020 Jun 15.
Autor:
Boroughs AC; Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA., Larson RC; Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA., Marjanovic ND; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA., Gosik K; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA., Castano AP; Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA., Porter CBM; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA., Lorrey SJ; Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA., Ashenberg O; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA., Jerby L; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA., Hofree M; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA., Smith-Rosario G; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA., Morris R; Howard Hughes Medical Institute, Koch Institute of Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02140, USA., Gould J; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA., Riley LS; Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA., Berger TR; Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA., Riesenfeld SJ; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA., Rozenblatt-Rosen O; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA., Choi BD; Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA., Regev A; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA; Howard Hughes Medical Institute, Koch Institute of Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02140, USA. Electronic address: aregev@broadinstitute.org., Maus MV; Cellular Immunotherapy Program and Cancer Center, Massachusetts General Hospital, Charlestown, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02139, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: mvmaus@mgh.harvard.edu.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2020 Dec 02; Vol. 28 (12), pp. 2577-2592. Date of Electronic Publication: 2020 Jul 25.
Autor:
Lorrey SJ; Department of Immunology, Duke University Graduate School, Durham, NC, USA.; Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, NC, USA., Kemeny HR; Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Northwestern University, Chicago, IL, USA., Fecci PE; Department of Immunology, Duke University Graduate School, Durham, NC, USA.; Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA.
Publikováno v:
Oncoscience [Oncoscience] 2020 Jun 01; Vol. 7 (5-6), pp. 38-39. Date of Electronic Publication: 2020 Jun 01 (Print Publication: 2020).
Autor:
Kemeny HR; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Duke University School of Medicine, Durham, North Carolina., Elsamadicy AA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Duke University School of Medicine, Durham, North Carolina., Farber SH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Duke University School of Medicine, Durham, North Carolina., Champion CD; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Duke University School of Medicine, Durham, North Carolina., Lorrey SJ; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Chongsathidkiet P; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Woroniecka KI; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Cui X; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Shen SH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Duke University School of Medicine, Durham, North Carolina., Rhodin KE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.; Duke University School of Medicine, Durham, North Carolina., Tsvankin V; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Everitt J; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Sanchez-Perez L; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Healy P; Department of Biostatistics, Duke University, Durham, North Carolina., McLendon RE; Department of Pathology, Duke University Medical Center, Durham, North Carolina., Codd PJ; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina., Dunn IF; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Fecci PE; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina. peter.fecci@duke.edu.; Duke University School of Medicine, Durham, North Carolina.; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Mar 01; Vol. 26 (5), pp. 1141-1151. Date of Electronic Publication: 2019 Nov 19.
Autor:
Ormhøj M; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Department of Clinical Immunology, Odense University Hospital, University of Southern Denmark, Odense, Denmark., Scarfò I; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Cabral ML; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Bailey SR; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Lorrey SJ; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Bouffard AA; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Castano AP; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Larson RC; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Riley LS; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Schmidts A; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Choi BD; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Andersen RS; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark., Cédile O; Haematology-Pathology Research Laboratory, Odense University Hospital, University of Southern Denmark, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark.; OPEN, Odense Patient Data Explorative Network, Odense University Hospital, Odense, Denmark., Nyvold CG; Haematology-Pathology Research Laboratory, Odense University Hospital, University of Southern Denmark, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark.; OPEN, Odense Patient Data Explorative Network, Odense University Hospital, Odense, Denmark., Christensen JH; Department of Haematology, Odense University Hospital, University of Southern Denmark, Odense, Denmark., Gjerstorff MF; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.; Department of Oncology, Odense University Hospital, Odense, Denmark., Ditzel HJ; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.; Department of Oncology, Odense University Hospital, Odense, Denmark., Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Barington T; Department of Clinical Immunology, Odense University Hospital, University of Southern Denmark, Odense, Denmark.; OPEN, Odense Patient Data Explorative Network, Odense University Hospital, Odense, Denmark., Frigault MJ; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Maus MV; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. mvmaus@mgh.harvard.edu.; Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Dec 01; Vol. 25 (23), pp. 7046-7057. Date of Electronic Publication: 2019 Aug 22.
Autor:
Lorrey SJ; Department of Immunology, Duke University Graduate School, Durham, NC, USA.; Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, NC, USA., Sanchez-Perez L; Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, NC, USA.; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA., Fecci PE; Department of Immunology, Duke University Graduate School, Durham, NC, USA. peter.fecci@duke.edu.; Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, NC, USA. peter.fecci@duke.edu.; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA. peter.fecci@duke.edu.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2019 Sep; Vol. 37 (9), pp. 1002-1003.